에 대한 최신 뉴스 BGM Group (NASDAQ:BGM) 주식

Qilian Intl Hldg Gr

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

D-Wave Quantum Inc

Equities

Mid Cap

News

Movers

MRUS

OKLO

QBTS

SBSW

D-웨이브 퀀텀, 어드밴스 오토파츠 등 지난주 급등한 중형주 7종목 (5월 19일~23일)

BGM Group Ltd

BG Medicine Inc

BERGAMO AQUISITION CORP by Bergamo Acquisition Corp.

Macro Economic Events

Econ #s

Economics

API Weekly Crude Oil Stock 4.236M Barrel Draw Vs 1.000M Barrel Build Est.; 2.499M Barrel Build Prior

C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) sees Q1 sales of $100.000 million-$109.000 million vs $105.40 million analyst estimate.

Guidance

C3.ai Sees Q1 Sales $100.000M-$109.000M vs $105.40M Est

Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) and Cadence Design Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) stocks moved lower on Wednesday after President Donald Trump&#8216;s administration ordered chip designers to stop selling to China.
What To Know: The move restricts access to software that is critical for semiconductor development, according to the&nbsp;<a href="https://www.ft.com/content/2c0db765-03ac-4820-8a02-806469848bee">Financial Times</a>. The restricted software includes key electronic design automation tools.
The decision comes amid an escalating U.S.-China tech trade war and further limits China's ability to develop advanced chips.
The policy shift also appeared to weigh on the broader market.
Price Action: At market close on Wednesday, Synopsys stock traded 9.64% lower at $462.43 and Cadence stock was down by 10.67% at $288.61, according to data from Benzinga Pro.
See Also: • <a href="https://www.benzinga.com/general/biotech/25/05/45655674/rocket-pharmas-gene-therapy-future-clouded-by-regulatory-uncertainty">Rocket Pharma&#8217;s Gene Therapy Future Clouded By Regulatory Uncertainty</a>
Photo: Shutterstock

CDNS

SNPS

What's Going On With Synopsys, Cadence Design Stocks Wednesday?

C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) sees FY2026 sales of $447.500 million-$484.500 million vs $467.19 million analyst estimate.

C3.ai Sees FY2026 Sales $447.500M-$484.500M vs $467.19M Est

WIIM

NVDA

Nvidia shares are trading higher after the company reported better-than-expected Q1 sales results.

SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. The company reported quarterly sales of $229.03 million which beat the analyst consensus estimate of $228.35 million by 0.30 percent. This is a 22.90 percent increase over sales of $186.35 million the same period last year.

Earnings

Earnings Beats

CORRECTION: SentinelOne Q1 Adj. EPS $0.02, Inline, Sales $229.03M Beat $228.35M Estimate

NVIDIA Q1 Data Center Revenue Up 10% QoQ, Gaming and AI PC Revenue Up 48%, Professional Visualization Revenue Flat, Automotive and Robotics Down 1%

BGM Group Ltd. (the "Company" or BGM)&nbsp; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGM#NASDAQ">BGM</a>) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to customary closing conditions. Upon completion, the shareholders of Xingdao Intelligent and YD Network will collectively hold approximately 15.6% of BGM's total outstanding share capital.

BGM Group To Acquire 100% Of Equity Interests Of Xingdao Intelligent And YD Network At Combined Valuation Of RMB800 Mln

Nordson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) reported quarterly earnings of $2.42 per share which beat the analyst consensus estimate of $2.36 by 2.54 percent. This is a 3.42 percent increase over earnings of $2.34 per share from the same period last year. The company reported quarterly sales of $682.94 million which beat the analyst consensus estimate of $674.04 million by 1.32 percent. This is a 4.96 percent increase over sales of $650.64 million the same period last year.

NDSN

Nordson Q2 Adj. EPS $2.42 Beats $2.36 Estimate, Sales $682.94M Beat $674.04M Estimate

BROG

Brooge Energy Announces Voluntarily Delists From Nasdaq

Snow Lake Resources Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) shares surged on Wednesday, closing up 18.18% to $4.29 after the company announced a strategic partnership with Exodys Energy to launch a new nuclear reactor development firm.
What To Know: The <a href="https://www.benzinga.com/pressreleases/25/05/45642522/snow-lake-and-exodys-energy-collaborate-to-support-the-formation-of-a-new-nuclear-reactor-developme">collaboration</a> supports Snow Lake's expansion into the nuclear sector, aligning with its broader diversification strategy following recent uranium acquisitions in Wyoming and an equity stake in Global Uranium and Enrichment.
The newly formed "reactor company" will focus on deploying small modular reactors using proven pressurized water reactor technology. This approach prioritizes regulatory readiness and leverages existing supply chains to meet the rising energy demands of AI-powered infrastructure and hyperscale data centers.
The announcement follows President Donald Trump's May 23 Executive Orders accelerating nuclear licensing and fuel security, providing strong policy tailwinds. Snow Lake will lead the commercial execution while Exodys provides technical support, particularly in nuclear fuel recycling.
Snow Lake CEO Frank Wheatley <a href="https://www.benzinga.com/pressreleases/25/05/45642522/snow-lake-and-exodys-energy-collaborate-to-support-the-formation-of-a-new-nuclear-reactor-developme">emphasized</a> the company's goal of becoming a vertically integrated nuclear player, from uranium mining to reactor deployment. Leadership for the new company will be announced in the coming weeks.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45653609/whats-going-on-with-nvidia-shares-today-2">What&#8217;s Going On With Nvidia Shares Today?</a>
<h2 class="wp-block-heading">How To Buy LITM Stock</h2>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Snow Lake Resources is in the Materials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LITM has a 52-week high of $24.44 and a 52-week low of $1.98.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/05/45654518/federal-reserve-minutes-flag-tariff-driven-inflation-eye-us-market-volatility-as-economic-risk">Federal Reserve Minutes Flag Tariff-Driven Inflation, Eye US Market Volatility As Economic Risk</a></li>
</ul>
Image: AI Generated

Commodities

LITM

Snow Lake Energy (LITM) Shares Soar On Strategic Nuclear Reactor Venture

Rising costs of living and stagnant wages are making it increasingly difficult for Americans to save and achieve their financial goals. A <a href="https://www.pewresearch.org/short-reads/2025/05/07/growing-share-of-us-adults-say-their-personal-finances-will-be-worse-a-year-from-now/">Pew Research</a> survey last month found that 48% of Americans have emergency funds that would only cover up to three months of expenses. However, with patience, discipline, and a long-term outlook, it&#8217;s still possible to build decent wealth even when times are tough.&nbsp;
A few months ago, a Redditor <a href="https://www.reddit.com/r/Money/comments/1i7o4z3/single_dad_hitting_100k_net_worth_feels_surreal/">shared</a> on the social media platform how he overcame his financial struggles in about four years through disciplined saving and hard work. He said he hit "rock bottom" in 2020 after his divorce and had a net worth of negative $32,000. He was living in a one-bedroom apartment with his daughter.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
"Hard to believe I&#8217;m writing this. 4 years ago I was drowning in debt, raising my 6-year-old daughter alone," he said, adding that he was "barely" making $45,000 in his retail management job when he began his journey out of debt.
At the time of his post, the Redditor had a total net worth of about $100,400, with about $58,000 in his 401(k), $26,700 in his emergency fund, $2,890 in investments, and the rest in his daughter's 529 plan.&nbsp;
The Redditor said it feels "surreal" to reach a net worth of $100,000 after facing major financial problems.
"Honestly, still paycheck to paycheck some months. But man, seeing that number hit six figures while my daughter sleeps soundly in her own room, worth every budget dinner and missed night out," he said.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
<h2 class="wp-block-heading">Automated Savings, Meal Preps and Two Promotions</h2>
The Redditor shared the key steps that helped him escape debt and reach a net worth of $100,000. He said he used every tax return and stimulus check to pay down his debt and set up automatic savings deductions from his paycheck. On Sundays, he would prepare meals with his daughter so they wouldn't need to eat out. The poster said he was also able to find remote work, which helped him reduce daycare expenses. He was promoted twice during this period and was now earning $65,000.
<h2 class="wp-block-heading">‘One Step at a Time'</h2>
He said he used the ROI app to track his savings and expenses, which "changed the game for me." His next goal is to build his daughter's college fund and save enough for a home down payment. He plans to move "one step at a time" and told fellow Redditors that "consistency is the key" to reach financial goals.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
Image: Shutterstock

Personal Finance

Single Dad Who Went From 'Drowning in Debt' to $100K Net Worth Shares His Journey Out of 'Rock Bottom' – 'Feels Surreal, Hard to Believe'

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 15 years by 3.84% on an annualized basis producing an average annual return of 15.61%. Currently, Equifax has a market capitalization of $32.56 billion. 
Buying $1000 In EFX: If an investor had bought $1000 of EFX stock 15 years ago, it would be worth $8,787.80 today based on a price of $262.14 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748464221_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 96.38% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 88.89% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 23.28% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 15.38% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 8.11% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 5.29% at $1.77</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.31% at $0.52</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 28.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 28.57% at $0.0005</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 25.38% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 10.68% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 7.14% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 5.61% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 4.72% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 4.55% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 4.24% at $1.13</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 3.88% at $0.77</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

CNBX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

CXXIF

FFNTF

FUAPF

GRWG

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

MGWFF

MRMD

RMHB

TGIFF

UGRO

XXII

Cannabis Stock Movers For May 28, 2025

Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) raises FY2025 sales outlook from $2.50 billion-$2.52 billion to $2.52 billion-$2.53 billion vs $2.51 billion estimate.

NTNX

Nutanix Raises FY2025 Sales Guidance from $2.50B-$2.52B to $2.52B-$2.53B vs $2.51B Est

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) raises FY2025 Adj EPS guidance from $14.88-$14.96 to $15.11-$15.19 vs $14.89 analyst estimate. Affirms FY2025 sales outlook from $6.75 billion-$6.80 billion to $6.75 billion-$6.80 billion vs $6.77 billion estimate.

Synopsys Raises FY2025 Adj EPS Guidance from $14.88-$14.96 to $15.11-$15.19 vs $14.89 Est; Affirms FY2025 Sales Guidance of $6.75B-$6.80B vs $6.77B Est

Valterra Platinum (OTCPK: AGPPF) made its trading debut on the Johannesburg Stock Exchange today, officially separating from Anglo American (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AAUKF#OTCQX">AAUKF</a>). The company, formerly Anglo American Platinum, is now a standalone entity and the <a href="https://www.benzinga.com/topic/platinum">world's largest platinum miner</a> by value.
"Part of our DNA is upholding those high standards and exemplifying who we are as a PGM producer," CEO Craig Miller said at the launch, per Reuters.
The spin-off grants Valterra operational independence while Anglo retains a 19.9% stake for at least 90 days, maintaining investor confidence during the transition. The company will also launch a secondary listing on the London Stock Exchange next week, broadening its investor base.
The split comes as part of Anglo American's broader restructuring effort following its escape from a <a href="https://www.benzinga.com/news/large-cap/24/05/39068033/time-runs-out-for-bhp-deal-49-billion-acquisition-of-anglo-american-proves-too-complex-to-solve">$49 billion takeover bid</a> by BHP last year. Anglo is now streamlining its focus on copper and iron ore, shedding its coking coal assets in Australia and nickel mines in Brazil. Investors are also watching closely to see whether De Beers, Anglo's <a href="https://www.benzinga.com/news/guidance/25/02/43523263/debeers-slashes-production-guidance-as-anglo-american-considers-another-goodwill-impairment">underperforming diamond unit</a>, will follow Valterra in being spun off or sold entirely.
Despite its strong asset base, Valterra debuts with debt on its books. A UBS report estimates that the company will enter net debt of 8.4 billion rand ($447 million) by the end of June, primarily due to demerger expenses and halted production.
Heavy floods in February forced the suspension of operations at the Tumela mine, with full production expected to resume mid-year. "The first half of the year is going to be a slower production period for us," Miller said <a href="https://www.miningmx.com/top-story/61295-valterra-shares-to-be-volatile-amid-challenging-first-half/">per</a> miningmx, but remained optimistic about a "really good second half."
The spinoff came at a good time as the platinum market showed signs of recovery, driven by concerns over long-term supply shortages and steady demand from the automotive and jewelry sectors.
Spot platinum increased 20% in Q2, moving from $900 to around $1,080 an ounce. According to the World Platinum Investment Council, global supply is expected to decline by 4% this year, contributing to a forecasted deficit of <a href="https://www.benzinga.com/news/guidance/25/03/44162528/platinum-set-for-another-year-of-deficits-as-supply-constraints-outpace-falling-demand">nearly 1 million ounces</a>.
Morgan Stanley analysts believe the fundamentals point to higher prices ahead. "The direction of travel for the platinum price is higher from here; however, the exact timing remains difficult to call," they wrote in a note, citing surging jewelry demand in China and reduced production in South Africa.
Despite a challenging market environment, institutions remain bullish on Valterra's long-term prospects. UBS analyst Steve Friedman called it a "top pick," citing its high-margin asset portfolio and leverage to a cyclical recovery.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45650179/uranium-stocks-hit-17-year-highs-as-mays-rally-marks-best-month-on-record">Uranium Stocks Hit 17-Year Highs As May&#8217;s Rally Marks Best Month On Record</a></li>
</ul>
Photo: Shutterstock

AAUKF

AGPPF

World's Largest Platinum Miner Debuts Into Tight Supply, Soaring Prices

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) is looking for Q3 Adj EPS of $3.82-$3.87 vs $3.96 analyst estimate. sees sales of $1.755 billion-$1.785 billion vs $1.76 billion analyst estimate.

Synopsys Sees Q3 Adj EPS $3.82-$3.87 vs $3.96 Est; Sees Sales $1.755B-$1.785B vs $1.76B Est

NAOV

NanoVibronix shares are trading higher. The company announced that a series of posts made earlier today regarding a $26 million registered direct offering were falsely issued.

Goldman Sachs analyst Noah Poponak downgraded Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) from Neutral to Sell, <a href="https://www.benzinga.com/quote/BAH/analyst-ratings" target="_blank" rel="noreferrer noopener">lowering the price forecast from $108 to $94.</a>
Poponak notes that revenue and earnings growth may remain limited over the medium term, with valuation still facing downside risk.
Medium-term revenue growth is now expected to be closer to flat, due to pressure on federal civilian spending and shifting priorities within the U.S. Department of Defense. Margins may also be at risk as contract structures evolve.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45587393/booz-allen-says-it-is-accelerating-the-administrations-priorities-but-its-annual-outlook-spooks-investors" rel="noreferrer noopener">Booz Allen Says It Is Accelerating &#8216;The Administration&#8217;s Priorities&#8217;, But Its Annual Outlook Spooks Investors</a>
Poponak points out that federal civilian agency budgets are under pressure, with other government spending areas taking priority.
Booz Allen Hamilton appears more frequently than peers on the DOGE contract cancellation site.
Several initiatives to cut federal civilian spending seem to be ongoing.
As a result, Booz Allen Hamilton&#8217;s organic revenue growth is now expected to be closer to flat for the next few years, which may take time for the stock to absorb after its strong growth over recent years.
The analyst highlights that companies in the sector are noting a shift toward more outcomes-based and fixed-price contracting.
This raises concerns as it places more risk on contractors and may pressure margins.
While firms may initially present this as an opportunity, since strong execution and contract terms can make it one, it remains difficult to get those elements &#8220;exactly right.&#8221;
BAH Price Action: Booz Allen Hamilton shares closed down by 4.70% to $104.66 on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45647143/global-stocks-hit-highest-level-since-2008-but-2025-edge-over-sp-500-slips-in-may" target="_blank" rel="noreferrer noopener">Wall Street Dominance Faces Crucial Test As Global Stocks Soar To 2008 Highs</a></li>
</ul>
Photo: Bigc Studio via Shutterstock

Downgrades

Analyst Ratings

General

Booz Allen Hamilton Downgraded: Analyst Flags Flat Revenue Growth, Margin Pressure

Press Releases

AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare

Insurance

In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI

BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in  Diversified Growth

BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform

BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

Fintech

From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

AIFU

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

BGM Group

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

지난주 최고의 성과를 올린 중형주는 다음과 같다.
<ol class="wp-block-list">
<li>D-웨이브 퀀텀(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) 주가는 53.47% 급등했다. 회사가 <a href="https://www.benzinga.com//node/45518005" target="_blank" rel="noreferrer noopener">최적화, AI, 및 재료 시뮬레이션</a> 문제를 해결하기 위해 어드밴티지 2(Advantage2) 양자 시스템을 출시했다고 발표했다.</li>
<li>리젠셀 바이오사이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) 주가는 지난 주 42.49% 상승했다.</li>
<li>어드밴스 오토파츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) 주가는 38.94% 증가했다. 회사가 <a href="https://www.benzinga.com//node/45567507" target="_blank" rel="noreferrer noopener">1분기 실적을 발표</a>한 후 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/aap/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 상향 조정</a>했다.</li>
<li>메루스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) 주가는 32.68% 상승했다. 회사는 <a href="https://www.benzinga.com//node/45576972">펨브롤리주맙(Pembrolizumab) 병용</a>하는 이중특이적 항체 페토셈타맙(petosemtamab)의 진행 중인 임상 2상 시험에서 2025년 2월 27일 데이터 컷오프 기준 중간 임상 데이터를 공개한 후 32.68% 상승했다.</li>
<li>오클로(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) 주가는 29.56% 상승했다. 이는 아마도 트럼프가 새로운 원자로에 대한 규제 <a href="https://www.benzinga.com//node/45590362" target="_blank" rel="noreferrer noopener">요건을 완화하는 행정명령을 서명할 것이라는 보도</a> 때문인 것으로 보인다.</li>
<li>시바니 스틸워터(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) 주가는 29.26% 상승했다.</li>
<li>BGM그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGM#NASDAQ">BGM</a>) 주가는 지난 주 27.20% 상승했다.</li>
</ol>
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

BGM Group

뉴스

에 대한 최신 뉴스 BGM Group (NASDAQ:BGM) 주식

일요일, 5월 25, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌